INAMED CORP
8-K, 1998-01-29
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
Previous: CERIDIAN CORP, 8-K, 1998-01-29
Next: GENERAL SECURITIES INC, NSAR-B, 1998-01-29




                       SECURITIES AND EXCHANGE COMMISSION

                              Washington, DC 20549

                              --------------------

                                    FORM 8-K

                                 CURRENT REPORT


                     Pursuant to Section 13 or 15(d) of the

                         Securities Exchange Act of 1934



         Date of Report (Date of earliest event reported): January 23, 1998

                               INAMED CORPORATION
- - ------------------------------------------------------------------------------
             (Exact name of registrant as specified in its charter)


       FLORIDA                    1-9741         59-0920629
- - ------------------------------------------------------------------------------
(State or other jurisdiction    (Commission       (IRS Employer
   of incorporation)            File Number)   Identification No.)

                      3800 Howard Hughes Parkway, Suite 900
                             Las Vegas, Nevada 89109
- - ------------------------------------------------------------------------------
                     Address of principal executive offices


Registrant's telephone number, including area code: (702) 791-3380


                                       N/A
- - ------------------------------------------------------------------------------
         (Former name or former address, if changed since last report.)


<PAGE>

Item 5.  OTHER EVENTS.

     On January  23,  1998,  Inamed  Corporation  (the  "Issuer")  issued a news
release,  disclosing  that Richard G. Babbitt has joined the Issuer as President
and Chief Executive Officer and Ilan K. Reich has joined the Issuer as Executive
Vice  President  and that Messrs.  Babbitt and Reich have been  appointed to the
Issuer's Board of Directors.

     For  additional   information   concerning  the  new  executive  and  board
appointments, reference is made to the news release, which is attached hereto as
an exhibit.

Item 7.  FINANCIAL STATEMENTS, PRO FORMA FINANCIAL
         INFORMATION AND EXHIBITS.

         (c)      EXHIBITS.

         99.1  News Release of Inamed Corporation dated January 23, 1998.


                                     Page 2

<PAGE>
                                    SIGNATURE

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                                        INAMED CORPORATION



Dated: January 28, 1998                 By:/s/ Donald K. McGhan
                                           ----------------------------------
                                        Name: Donald K. McGhan
                                        Title: Chairman and Chief
                                               Executive Officer


                                     Page 3

<PAGE>
                                  EXHIBIT INDEX

     99.1  News Release of Inamed Corporation dated January 23, 1998.


                                     Page 4



INAMED "Innovation in Medicine"                INAMED CORPORATION
                                               3800 Howard Hughes Parkway
                                               Suite 900
                                               Las Vegas, NV 89109
                                               (702) 791-3388
                                               Fax:  (702) 791-1922

NEWS RELEASE
FOR IMMEDIATE RELEASE

COMPANY CONTACT:    DONALD K. MCGHAN
                    (702) 791-3388

                          INAMED CORPORATION ANNOUNCES
                         NEW OFFICERS AND BOARD MEMBERS


LAS VEGAS,  NEVADA - January 23, 1998 - Inamed  Corporation (OTC Bulletin Board:
IMDC),  a global  surgical  and medical  device  company,  announced  today that
Richard G.  Babbitt  has joined the  Company as  President  and Chief  Executive
Officer and Ilan K. Reich has joined the Company as  Executive  Vice  President.
Messrs. Babbitt and Reich have also been appointed to the Board of Directors.

In connection with this appointment,  Donald K. McGhan will continue to serve as
the Company's Chairman of the Board, a position that he has held since 1985. Jim
J. McGhan will  relinquish  the title of  President  and serve as the  Company's
Chief Operating Officer.  

Mr.  Babbitt has been the  President  and Chief  Executive  Officer of a private
company,  DNA Technologies,  Inc. Previously Mr. Babbitt served as President and
General  manager of Ben Hogan  Group;  President  of American  Safety  Equipment
Corporation  during  its  acquisition  by  Allied  Signal;   President  of  B.I.
Industries  during its  acquisition by American  Safety  Equipment  Corporation;
Chief  Executive  Officer  of Welsh  Manufacturing  during  its  acquisition  by
Textron;  and President of Medical  Supply  Company  during its  acquisition  by
Marion  Laboratories.  Mr. Babbitt is a graduate of Purdue University and was an
officer in the U.S. Marine Corps.

Mr.  Reich is a  partner  at the New York law firm of  Olshan  Grundman  Frome &
Rosenzweig, LLP, specializing in corporate and securities law. From 1988 to June
1996,  Mr. Reich served in various  senior  executive  positions with public and
private companies  controlled by a private  investor,  including Vice President,
Special Projects,  at Western Publishing Group, Inc., the largest U.S. publisher
of children's books, and Vice President,  Business Development,  at Rabco Health

                                     -more-

<PAGE>

Services,  Inc.,  a  distributor  of  medical/surgical  products and a wholesale
pharmaceutical  company.  Earlier in his career,  Mr. Reich was a partner at the
New York law firm of Wachtell,  Lipton, Rosen & Katz,  specializing in corporate
law and mergers and  acquisitions.  Mr. Reich is a graduate of Columbia  College
and Columbia Law School.

In making the announcement, Chairman Donald K. McGhan, stated "We are pleased to
announce the addition of the two  Executive  Officers and Board  members who are
joining INAMED  Corporation at the same time. Richard Babbitt brings a wealth of
successful  top  management  experience  in all  aspects  of  business."  McGhan
continued:  "Mr. Reich brings a unique  combination of legal and business skills
to INAMED. He has developed  significant  insight into the Company over the past
nine months  during  which time he has been an outside  legal  advisor  actively
involved in negotiations on the breast implant  litigation with our lenders.  We
are pleased to have convinced both Richard and Ilan to accept the opportunity to
join INAMED's  talented,  experienced  and worldwide work force in moving toward
our goal of  achieving  mandatory,  non-opt-out  settlement  of  breast  implant
litigation and subsequent profitability."

Richard Wm. Talley,  Chairman of the Company's  Audit  Committee,  added,  "Ilan
Reich has been advising the Board of Directors on various  issues ever since the
Shareholders'  Rights Plan was approved last year. During that time, the members
of the Audit  Committee have gained great respect for his knowledge of corporate
law and business sense. Along with Richard Babbitt,  the Company's new President
and Chief Executive Officer, and Tom Pilholski,  the Chief Financial Officer who
joined us on December 1, 1997,  the Audit  Committee is convinced that INAMED is
focused  on  establishing  and  maintaining   world-class  financial  management
practices and controls within the organization."

INAMED Corporation has 26 operating  subsidiaries in the United States,  Europe,
Mexico, Latin America and Asia. The subsidiaries are engaged in the development,
manufacturing   and   marketing   of  medical   devices   for  the  plastic  and
reconstructive,  bariatric and general surgery markets.  INAMED is headquartered
in Las Vegas, Nevada.

                                      ###



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission